Drug Type Non-recombinant coagulation factor |
Synonyms Alphanate, Factor VIII/von Willebrand factor, Fanhdi + [1] |
Target |
Action stimulants |
Mechanism F10 stimulants(Coagulation factor X stimulants), Blood coagulation pathway activation, Coagulation factor VIII replacements + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (15 Aug 1978), |
RegulationOrphan Drug (United States) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Antihemophilic factor/von Willebrand factor complex(Grifols SA) | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Factor 8 Deficiency, Acquired | United States | 15 Aug 1978 | |
Hemophilia A | United States | 15 Aug 1978 | |
Von Willebrand Diseases | United States | - | 15 Aug 1978 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemophilia A | Phase 2 | India | 03 Jan 2018 | |
Hemophilia A | Phase 2 | Spain | 03 Jan 2018 | |
Hemophilia A | Phase 2 | Canada | 03 Jan 2018 | |
Hemophilia A | Phase 2 | Russia | 03 Jan 2018 | |
Hemophilia A | Phase 2 | Spain | 03 Jan 2018 | |
Hemophilia A | Phase 2 | Italy | 03 Jan 2018 | |
Hemophilia A | Phase 2 | Canada | 03 Jan 2018 | |
Hemophilia A | Phase 2 | Italy | 03 Jan 2018 | |
Hemophilia A | Phase 2 | India | 03 Jan 2018 | |
Hemophilia A | Phase 2 | Russia | 03 Jan 2018 |
Phase 4 | 51 | Factor VIII (FVIII)+Alphanate | jatqvuxtgk(vailxvfbgd) = xcsqnieldg bfwehllprz (vqqoqkubcz, lkzmvjoull - aweuxfgcek) View more | - | 09 Jun 2022 | ||
Phase 2 | 2 | rofzpqrzsr(wrlvxydkkz) = tavxchqftn uxuwmdfjvr (orkduzcpve, cgyuoeaine - vnyjsslubv) View more | - | 23 Nov 2021 | |||
Not Applicable | - | lifzrezzum(ladekgdqey) = kuannlhget fbdtbjcidy (drnhoaywgd ) View more | Positive | 12 Jul 2020 |